PETER A CLEMENS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for PETER A CLEMENS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of PETER A CLEMENS. PETER A CLEMENS is Senior VP & CFO in ACURA PHARMACEUTICALS, INC ($ACUR) and Senior VP and CFO in ACURA PHARMACEUTICALS, INC ($ACUR).
Latest Insider Trading Transactions of PETER A CLEMENS
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2021 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP & CFO | Option Exercise | M | 0.15 | 40,000 | 6,040 | 0 | |
| Feb 26 2021 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP & CFO | Payment of Exercise | F | 0.40 | 15,100 | 6,040 | 416,097 | 431.2 K to 416.1 K (-3.50 %) |
| Feb 26 2021 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP & CFO | Buy | M | 0.15 | 40,000 | 6,040 | 431,197 | 391.2 K to 431.2 K (+10.23 %) |
| Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP & CFO | Option Exercise | M | 0.01 | 40,000 | 400 | 89,332 | |
| Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP & CFO | Option Exercise | M | 0.01 | 9,334 | 93 | 129,332 | |
| Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP & CFO | Payment of Exercise | F | 0.21 | 19,514 | 4,098 | 391,197 | 410.7 K to 391.2 K (-4.75 %) |
| Jan 06 2021 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP & CFO | Buy | M | 0.00 | 49,334 | 0 | 410,711 | 361.4 K to 410.7 K (+13.65 %) |
| Jan 06 2020 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP & CFO | Option Exercise | M | 0.01 | 9,334 | 93 | 138,666 | |
| Jan 06 2020 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP & CFO | Payment of Exercise | F | 0.23 | 3,090 | 711 | 361,377 | 364.5 K to 361.4 K (-0.85 %) |
| Jan 06 2020 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP & CFO | Buy | M | 0.00 | 9,334 | 0 | 364,467 | 355.1 K to 364.5 K (+2.63 %) |
| Dec 17 2018 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP & CFO | Option Exercise | A | 0.15 | 40,000 | 6,040 | 40,000 | |
| Dec 17 2018 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP & CFO | Option Exercise | A | 0.01 | 120,000 | 1,200 | 120,000 | |
| Dec 15 2017 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Buy | P | 0.10 | 300,000 | 30,000 | 355,182 | 55.2 K to 355.2 K (+543.66 %) |
| Dec 11 2017 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Option Exercise | A | 0.00 | 28,000 | 0 | 28,000 | |
| Aug 10 2017 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Option Exercise | A | 0.45 | 34,000 | 15,300 | 34,000 | |
| Dec 12 2016 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Option Exercise | A | 0.92 | 34,000 | 31,110 | 34,000 | |
| Dec 14 2015 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Option Exercise | A | 2.01 | 50,000 | 100,500 | 50,000 | |
| Dec 12 2014 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Option Exercise | A | 0.52 | 180,000 | 93,600 | 180,000 | |
| May 16 2014 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Sell | P | 1.21 | 3,000 | 3,621 | 275,918 | 278.9 K to 275.9 K (-1.08 %) |
| Mar 03 2014 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Option Exercise | M | 1.30 | 9,375 | 12,188 | 0 | |
| Mar 03 2014 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Payment of Exercise | F | 2.03 | 883 | 1,792 | 272,913 | 273.8 K to 272.9 K (-0.32 %) |
| Mar 03 2014 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Payment of Exercise | F | 2.03 | 6,004 | 12,188 | 273,796 | 279.8 K to 273.8 K (-2.15 %) |
| Mar 03 2014 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Buy | M | 1.30 | 9,375 | 12,188 | 279,800 | 270.4 K to 279.8 K (+3.47 %) |
| Jan 03 2014 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Payment of Exercise | F | 1.67 | 56,787 | 94,834 | 270,425 | 327.2 K to 270.4 K (-17.35 %) |
| Jan 03 2014 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Payment of Exercise | F | 1.67 | 704 | 1,176 | 327,212 | 327.9 K to 327.2 K (-0.21 %) |
| Dec 19 2013 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Option Exercise | M | 1.30 | 9,375 | 12,188 | 9,375 | |
| Dec 19 2013 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Payment of Exercise | F | 1.54 | 256 | 394 | 327,471 | 327.7 K to 327.5 K (-0.08 %) |
| Dec 19 2013 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Payment of Exercise | F | 1.54 | 7,914 | 12,188 | 327,727 | 335.6 K to 327.7 K (-2.36 %) |
| Dec 19 2013 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Buy | M | 1.30 | 9,375 | 12,188 | 335,641 | 326.3 K to 335.6 K (+2.87 %) |
| Dec 13 2013 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Option Exercise | A | 1.55 | 75,000 | 116,250 | 75,000 | |
| Jan 07 2013 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Payment of Exercise | F | 2.22 | 530 | 1,177 | 326,266 | 326.8 K to 326.3 K (-0.16 %) |
| Jan 07 2013 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Payment of Exercise | F | 2.22 | 51,294 | 113,873 | 326,796 | 378.1 K to 326.8 K (-13.57 %) |
| Dec 17 2012 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Option Exercise | A | 2.61 | 50,000 | 130,500 | 50,000 | |
| Mar 21 2012 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Sell | S | 3.86 | 10,000 | 38,575 | 378,090 | 388.1 K to 378.1 K (-2.58 %) |
| Jan 04 2012 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Option Exercise | M | 1.30 | 9,375 | 12,188 | 18,750 | |
| Jan 04 2012 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Payment of Exercise | F | 3.49 | 337 | 1,176 | 388,090 | 388.4 K to 388.1 K (-0.09 %) |
| Jan 04 2012 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Payment of Exercise | F | 3.49 | 49,360 | 172,266 | 388,427 | 437.8 K to 388.4 K (-11.27 %) |
| Jan 04 2012 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Payment of Exercise | F | 3.49 | 2,052 | 7,161 | 437,787 | 439.8 K to 437.8 K (-0.47 %) |
| Jan 04 2012 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Payment of Exercise | F | 3.49 | 3,493 | 12,191 | 439,839 | 443.3 K to 439.8 K (-0.79 %) |
| Jan 04 2012 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Buy | M | 1.30 | 9,375 | 12,188 | 443,782 | 434.4 K to 443.8 K (+2.16 %) |
| Dec 19 2011 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Option Exercise | A | 3.72 | 35,000 | 130,200 | 35,000 | |
| Aug 15 2011 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Buy | P | 2.65 | 1,000 | 2,650 | 3,605 | 2.6 K to 3.6 K (+38.39 %) |
| Aug 15 2011 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Buy | P | 2.68 | 2,500 | 6,700 | 434,907 | 432.4 K to 434.9 K (+0.58 %) |
| Jan 26 2011 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Option Exercise | M | 1.30 | 9,375 | 12,188 | 28,125 | |
| Jan 26 2011 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Buy | P | 2.98 | 350 | 1,043 | 2,605 | 2.3 K to 2.6 K (+15.52 %) |
| Jan 26 2011 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Buy | M | 1.30 | 9,375 | 12,188 | 437,187 | 427.8 K to 437.2 K (+2.19 %) |
| Jan 04 2011 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Payment of Exercise | F | 3.31 | 47,268 | 156,457 | 427,812 | 475.1 K to 427.8 K (-9.95 %) |
| Dec 20 2010 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Option Exercise | A | 3.02 | 40,000 | 120,800 | 40,000 | |
| Apr 27 2009 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Option Exercise | A | 6.29 | 120,000 | 754,800 | 120,000 | |
| Apr 27 2009 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Grant | A | 0.00 | 30,000 | 0 | 470,300 | 440.3 K to 470.3 K (+6.81 %) |
| May 23 2008 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Option Exercise | A | 9.87 | 100,000 | 987,000 | 100,000 | |
| Nov 13 2007 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Sell | S | 1.05 | 60,566 | 63,594 | 4,403,002 | 4.5 M to 4.4 M (-1.36 %) |
| Nov 13 2007 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Sell | S | 1.09 | 2,000 | 2,180 | 4,463,568 | 4.5 M to 4.5 M (-0.04 %) |
| Nov 13 2007 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Sell | S | 1.10 | 46,000 | 50,600 | 4,465,568 | 4.5 M to 4.5 M (-1.02 %) |
| Nov 13 2007 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Sell | S | 1.18 | 17,000 | 20,060 | 4,511,568 | 4.5 M to 4.5 M (-0.38 %) |
| Nov 13 2007 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Sell | S | 1.19 | 40,800 | 48,552 | 4,528,568 | 4.6 M to 4.5 M (-0.89 %) |
| Nov 13 2007 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Sell | S | 1.20 | 17,500 | 21,000 | 4,569,368 | 4.6 M to 4.6 M (-0.38 %) |
| Nov 13 2007 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Sell | S | 1.25 | 23,500 | 29,375 | 4,586,868 | 4.6 M to 4.6 M (-0.51 %) |
| Nov 13 2007 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Sell | S | 1.25 | 6,140 | 7,675 | 4,610,368 | 4.6 M to 4.6 M (-0.13 %) |
| Nov 13 2007 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Sell | S | 1.26 | 18,000 | 22,732 | 4,616,508 | 4.6 M to 4.6 M (-0.39 %) |
| Nov 13 2007 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Sell | S | 1.35 | 30,000 | 40,500 | 4,634,508 | 4.7 M to 4.6 M (-0.64 %) |
| Nov 13 2007 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Sell | S | 1.50 | 3,000 | 4,500 | 4,664,508 | 4.7 M to 4.7 M (-0.06 %) |
| Aug 13 2004 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Option Exercise | C | 0.00 | 22,557 | 0 | 22,557 | |
| Aug 13 2004 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Option Exercise | C | 0.00 | 25,258 | 0 | 25,258 | |
| Aug 13 2004 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Option Exercise | C | 0.00 | 221,458 | 0 | 221,458 | |
| Aug 13 2004 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Option Exercise | C | 0.58 | 13,029 | 7,526 | 0 | |
| Aug 13 2004 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Option Exercise | C | 0.58 | 14,589 | 8,427 | 0 | |
| Aug 13 2004 | ACUR | ACURA PHARMACEUTIC ... | CLEMENS PETER A | Senior VP and CFO | Option Exercise | C | 0.58 | 127,914 | 73,883 | 0 |
Page: 1